Fig. 5 | Scientific Reports

Fig. 5

From: A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer

Fig. 5

ADAM and MICA protein expression in the combined sets of serum samples of patients with early gastric cancer and healthy controls. Expression levels of (A) ADAM10 (p < 0.001), (B) ADAM12 (p < 0.001), (C) ADAM17 (p = 0.702), and (D) MICA (p = 0.812) were examined using ELISA in serum samples obtained from patients with early gastric cancer (case, n = 25 [n = 24 for ADAM12], shown in red) and healthy controls (control, n = 26 [n = 25 for ADAM12], shown in blue). *p < 0.05, **p < 0.005, ***p < 0.001, ****p < 0.0001, ns. not specific; t-test or Mann–Whitney U test.

Back to article page